BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

MAbSilico

MAbSilico logo

Founded
2017
Geography
France based
Funding
$1.110 M

MAbSilico is a deeptech company from French academic research labs. Founded in 2017, MAbSilico is a software editor with the vision to accelerate the development of therapeutic antibody focusing on the early stage development to provide leads in a few years today to a few weeks.

MAbSilico is developing a software suite combining algorithms and databases based on 20 years of proven research and protected by patent. Our Artificial Intelligence and machine learning -driven tools cover two key steps of the early-stage antibody development; the lead identification and the lead characterization.

Technologies

AI Companies (Drug Discovery)  

R&D Platform


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet